These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8081629)

  • 21. Stop-codon read-through for patients affected by a lysosomal storage disorder.
    Brooks DA; Muller VJ; Hopwood JJ
    Trends Mol Med; 2006 Aug; 12(8):367-73. PubMed ID: 16798086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of oligosaccharides and glycolipids in amniotic fluid by electrospray ionisation tandem mass spectrometry: in utero indicators of lysosomal storage diseases.
    Ramsay SL; Maire I; Bindloss C; Fuller M; Whitfield PD; Piraud M; Hopwood JJ; Meikle PJ
    Mol Genet Metab; 2004 Nov; 83(3):231-8. PubMed ID: 15542394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Skin biopsy: a useful tool in the diagnosis of lysosomal storage diseases.
    Alroy J; Ucci AA
    Ultrastruct Pathol; 2006; 30(6):489-503. PubMed ID: 17182441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematic approach to the diagnosis of lysosomal storage disorders.
    Weibel TD; Brady RO
    Ment Retard Dev Disabil Res Rev; 2001; 7(3):190-9. PubMed ID: 11553935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Allogeneic bone marrow transplantation in the treatment of (lysosomal) storage diseases].
    Maaswinkel-Mooij PD; Poorthuis BJ; Hoogerbrugge PM; Brouwer OF; Vossen JM
    Ned Tijdschr Geneeskd; 1998 Jan; 142(4):169-74. PubMed ID: 9557021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Movement disorders and neurometabolic diseases].
    Grabli D; Auré K; Roze E
    Rev Neurol (Paris); 2011 Feb; 167(2):123-34. PubMed ID: 21087782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current and emerging therapies for the lysosomal storage disorders.
    Pastores GM; Barnett NL
    Expert Opin Emerg Drugs; 2005 Nov; 10(4):891-902. PubMed ID: 16262569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical spectrum of infantile free sialic acid storage disease.
    Lemyre E; Russo P; Melançon SB; Gagné R; Potier M; Lambert M
    Am J Med Genet; 1999 Feb; 82(5):385-91. PubMed ID: 10069709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 'Doctor Google' ending the diagnostic odyssey in lysosomal storage disorders: parents using internet search engines as an efficient diagnostic strategy in rare diseases.
    Bouwman MG; Teunissen QG; Wijburg FA; Linthorst GE
    Arch Dis Child; 2010 Aug; 95(8):642-4. PubMed ID: 20418338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebral white matter involvement in children with mitochondrial encephalopathies.
    Moroni I; Bugiani M; Bizzi A; Castelli G; Lamantea E; Uziel G
    Neuropediatrics; 2002 Apr; 33(2):79-85. PubMed ID: 12075488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Normal and abnormal patterns of myelin development of the fetal and infantile human brain using magnetic resonance imaging.
    Grodd W
    Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):393-7. PubMed ID: 8507909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MRI in paediatric hypoxic-ischemic disease, metabolic disorders and malformations-a review.
    Beitzke D; Simbrunner J; Riccabona M
    Eur J Radiol; 2008 Nov; 68(2):199-213. PubMed ID: 18799278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Musculoskeletal complications encountered in the lysosomal storage disorders.
    Pastores GM
    Best Pract Res Clin Rheumatol; 2008 Oct; 22(5):937-47. PubMed ID: 19028373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene therapy for the lysosomal storage disorders.
    Cabrera-Salazar MA; Novelli E; Barranger JA
    Curr Opin Mol Ther; 2002 Aug; 4(4):349-58. PubMed ID: 12222873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I.
    Kakkis E; McEntee M; Vogler C; Le S; Levy B; Belichenko P; Mobley W; Dickson P; Hanson S; Passage M
    Mol Genet Metab; 2004; 83(1-2):163-74. PubMed ID: 15464431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid diagnostic testing procedures for lysosomal storage disorders: alpha-glucosidase and beta-galactosidase assays on dried blood spots.
    Gasparotto N; Tomanin R; Frigo AC; Niizawa G; Pasquini E; Blanco M; Donati MA; Keutzer J; Zacchello F; Scarpa M
    Clin Chim Acta; 2009 Apr; 402(1-2):38-41. PubMed ID: 19111682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Localized proton magnetic resonance spectroscopy of the brain differentiates the inborn metabolic encephalopathies in children.
    Chabrol B; Salvan AM; Confort-Gouny S; Vion-Dury J; Cozzone PJ
    C R Acad Sci III; 1995 Sep; 318(9):985-92. PubMed ID: 8521083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lysosomal storage disorders: A review of the musculoskeletal features.
    James RA; Singh-Grewal D; Lee SJ; McGill J; Adib N;
    J Paediatr Child Health; 2016 Mar; 52(3):262-71. PubMed ID: 27124840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic disorders of the brain: part I.
    Kanekar S; Gustas C
    Semin Ultrasound CT MR; 2011 Dec; 32(6):590-614. PubMed ID: 22108221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.